However, in a separate study, AKT3 overexpression reduced cell-cycle progression and cell survival in human glioblastoma cell lines, and increased the tumour survival of mice with orthotopic injection of glioblastoma cells [72]. The gene discussed is AKT3; the disease is neoplasm.